Status:
COMPLETED
Bioequivalence Study of Patches With Different Equilibration Profiles
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Female Contraception
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this single center, randomized, double-blind, 2 way crossover study was to determine the bioequivalence of a norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.
Detailed Description
The primary objective was to determine the bioequivalence of a norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system lot with a faster equilibration profile compared to currently...
Eligibility Criteria
Inclusion
- Healthy as determined by physical and gynecologic examinations, clinical laboratory assessments, vital sign measurements, and a 12-lead electrocardiogram (ECG)
Exclusion
- Pregnant
- Lactating
- Currently using hormonal contraceptive
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00775086
Start Date
May 1 2004
End Date
August 1 2004
Last Update
June 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.